Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,924 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome.
Suh KJ, Cheong JW, Kim I, Kim HJ, Shin DY, Koh Y, Yoon SS, Min YH, Ahn JS, Kim YK, Lee YG, Lee JO, Bang SM, Mun YC, Seong CM, Park Y, Kim BS, Hong J, Park J, Lee JH, Kim SY, Lee HG. Suh KJ, et al. Among authors: kim bs, kim hj, kim yk, kim sy, kim i. PLoS One. 2016 Nov 8;11(11):e0166245. doi: 10.1371/journal.pone.0166245. eCollection 2016. PLoS One. 2016. PMID: 27824923 Free PMC article.
Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.
Lee YG, Kim I, Yoon SS, Park S, Cheong JW, Min YH, Lee JO, Bang SM, Yi HG, Kim CS, Park Y, Kim BS, Mun YC, Seong CM, Park J, Lee JH, Kim SY, Lee HG, Kim YK, Kim HJ; Korean Society of Haematology AML/MDS working party. Lee YG, et al. Among authors: kim cs, kim bs, kim yk, kim hj, kim sy, kim i. Br J Haematol. 2013 May;161(3):339-47. doi: 10.1111/bjh.12256. Epub 2013 Feb 21. Br J Haematol. 2013. PMID: 23432512 Free article. Clinical Trial.
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome.
Ahn JS, Kim YK, Min YH, Cheong JW, Jang JH, Jung CW, Kim IH, Yoon HJ, Lee HG, Sohn SK, Moon JH, Kim H, Kim YJ, Won JH, Chung JS, Mun YC, Lee JH, Kim HJ. Ahn JS, et al. Among authors: kim ih, kim h, kim yj, kim yk, kim hj. Acta Haematol. 2015;134(1):40-8. doi: 10.1159/000368711. Epub 2015 Jun 6. Acta Haematol. 2015. PMID: 26066466 Clinical Trial.
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.
Jeong SH, Kim YJ, Lee JH, Kim YK, Kim SJ, Park SK, Do YR, Kim I, Mun YC, Kim HG, Lee WS, Yi HG, Joo YD, Choi CW, Kim SR, Na SM, Jang JH. Jeong SH, et al. Among authors: kim hg, kim sr, kim yj, kim yk, kim sj, kim i. Oncotarget. 2015 Dec 29;6(42):44985-94. doi: 10.18632/oncotarget.6242. Oncotarget. 2015. PMID: 26517692 Free PMC article.
Guidelines for the management of myeloproliferative neoplasms.
Choi CW, Bang SM, Jang S, Jung CW, Kim HJ, Kim HY, Kim SJ, Kim YK, Park J, Won JH. Choi CW, et al. Among authors: kim hy, kim hj, kim yk, kim sj. Korean J Intern Med. 2015 Nov;30(6):771-88. doi: 10.3904/kjim.2015.30.6.771. Epub 2015 Oct 30. Korean J Intern Med. 2015. PMID: 26552452 Free PMC article. Review.
Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen.
Jung SH, Cho MS, Kim HK, Kim SJ, Kim K, Cheong JW, Kim SJ, Kim JS, Ahn JS, Kim YK, Yang DH, Kim HJ, Lee JJ; Korean Multiple Myeloma Working Party (KMMWP). Jung SH, et al. Among authors: kim yk, kim hj, kim hk, kim sj, kim js, kim k. BMC Cancer. 2016 Aug 8;16:613. doi: 10.1186/s12885-016-2645-y. BMC Cancer. 2016. PMID: 27501959 Free PMC article.
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea.
Shin J, Koh Y, Yoon SH, Cho JY, Kim DY, Lee KH, Kim HJ, Ahn JS, Kim YK, Park J, Sohn SK, Moon JH, Lee YJ, Yoon S, Lee JO, Cheong JW, Kim KH, Kim SH, Kim HG, Kim H, Nam SH, Do YR, Park SG, Park SK, Bae SH, Song HH, Shin DY, Oh D, Kim MK, Jung CW, Park S, Kim I. Shin J, et al. Among authors: kim hg, kim h, kim hj, kim yk, kim dy, kim sh, kim i, kim kh, kim mk. Cancer Med. 2018 May;7(5):1814-1823. doi: 10.1002/cam4.1450. Epub 2018 Mar 25. Cancer Med. 2018. PMID: 29577674 Free PMC article. Clinical Trial.
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System.
Jung KS, Kim YJ, Kim YK, Park SK, Kim HG, Kim SJ, Park J, Choi CW, Do YR, Kim I, Park S, Mun YC, Jeong SH, Kim MK, Yi HG, Chang MH, Kim SY, Lee JH, Jang JH. Jung KS, et al. Among authors: kim hg, kim yj, kim yk, kim sy, kim sj, kim i, kim mk. Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):656-664. doi: 10.1016/j.clml.2019.06.003. Epub 2019 Jun 27. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31375393
5,924 results